Biotechnology consultant specializing in business development, corporate strategy, and opportunity assessment.

Numerate is a privately held biotechnology company focused on making the drug design process more data-driven, efficient and predictable. Numerate’s platform combines advances in computer science and statistics with traditional medicinal chemistry approaches to address, in parallel, the factors that determine the success and failure of a drug candidate. Numerate applies this proprietary platform to design and develop small molecule therapeutics in collaboration with a variety of partners in the pharmaceutical, biotechnology, and academic fields. For more information, please visit www.numerate.com

Presidio is an early-stage antiviral therapeutics company growing via in-licensing of late stage compounds (clinical and late preclinical), as well as through early-stage technology development.